Investors / filer profile

Dier Mardi

EVP and CFO

active in 1 company

Pro
Bought: Pro
Sold: 17
Filings: 1
Companies: 2026-03-02
Last filed

EDGAR · CIK 0001574591 ↗

Track record

How each disclosed position did against the S&P ~6 months later

No positions we can measure against the market yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$0.0000 bought · −$2.92M sold

All filings on record

Every Form 4 transaction we track for this filer


MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $505.4K · 1,183 sh	2026-03-02	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $47.7K · 80 sh	2025-12-02	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $44.0K · 74 sh	2025-12-02	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $94.5K · 160 sh	2025-12-02	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $94.3K · 160 sh	2025-12-02	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $141.1K · 240 sh	2025-12-02	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $140.5K · 240 sh	2025-12-02	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $278.3K · 480 sh	2025-12-02	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $149.3K · 258 sh	2025-12-02	—
MDGLMADRIGAL PHARMACEUTICALS, INC.	Sell $184.9K · 320 sh	2025-12-02	—

MDGLSell

2026-03-02 · MADRIGAL PHARMACEUTICALS, INC.

$505.4K

—

MDGLSell

2025-12-02 · MADRIGAL PHARMACEUTICALS, INC.

$47.7K

—

MDGLSell

2025-12-02 · MADRIGAL PHARMACEUTICALS, INC.

$44.0K

—

MDGLSell

2025-12-02 · MADRIGAL PHARMACEUTICALS, INC.

$94.5K

—

MDGLSell

2025-12-02 · MADRIGAL PHARMACEUTICALS, INC.

$94.3K

—

MDGLSell

2025-12-02 · MADRIGAL PHARMACEUTICALS, INC.

$141.1K

—

MDGLSell

2025-12-02 · MADRIGAL PHARMACEUTICALS, INC.

$140.5K

—

MDGLSell

2025-12-02 · MADRIGAL PHARMACEUTICALS, INC.

$278.3K

—

MDGLSell

2025-12-02 · MADRIGAL PHARMACEUTICALS, INC.

$149.3K

—

MDGLSell

2025-12-02 · MADRIGAL PHARMACEUTICALS, INC.

$184.9K

—

Newest 10 of 17 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.